Leonard Bell has sold ALXN and made no open-market buys since Feb 2016
Director at Alexion Pharmaceuticals, Inc.
SEC CIK 0001231949 · Filings on SEC.gov ↗
$0Bought
$15.6MSold
NoneLast buy
Every filing
9 filings since Feb 2016, newest first
ALXNSell
Alexion Pharmaceuticals Inc
Director
$525K−1.0%Mar 1
ALXNSell
Alexion Pharmaceuticals Inc
Director
$31KFeb 10
ALXNSell
Alexion Pharmaceuticals Inc
Director
$1.1M−2.0%Feb 8
ALXNSell
Alexion Pharmaceuticals Inc
Director
$5.5M−5.0%Jan 9
ALXNSell
Alexion Pharmaceuticals Inc
Director
$5.2M−4.0%Nov 7
ALXNSell
Alexion Pharmaceuticals Inc
Director
$221KNov 2
ALXNSell
Alexion Pharmaceuticals Inc
Director
$139KAug 10
ALXNSell
Alexion Pharmaceuticals Inc
Director
$555K−1.0%Mar 1
ALXNSell
Alexion Pharmaceuticals Inc
Director
$2.2M−2.0%Feb 8
Filings come from SEC EDGAR. Not investment advice.